Uveitis & Ocular Inflammation – Immune Insights

Uveitis represents a diverse group of inflammatory disorders often linked to autoimmune conditions, infections, or systemic disease. Advances in imaging, including OCT and fluorescein angiography, support earlier detection of inflammatory changes affecting the uveal tract and retina. Biomarker research and cytokine profiling provide deeper insights into immune pathways driving chronic inflammation, enabling more targeted therapeutic strategies. Biologic agents, corticosteroid implants, and immunomodulatory medications are improving long-term control while reducing treatment-related complications. Novel drug-delivery systems, including sustained-release formulations, provide consistent anti-inflammatory effects with reduced systemic exposure. Precision diagnostics help identify infectious etiologies and guide appropriate antimicrobial management. Multidisciplinary collaboration enhances outcomes for individuals with systemic associations such as sarcoidosis, Behçet’s disease, and juvenile idiopathic arthritis. These integrated advancements support more effective inflammation control, preservation of visual function, and improved quality of life.

    Related Conference of Uveitis & Ocular Inflammation – Immune Insights

    January 12-13, 2026

    26th Global Ophthalmologists Annual Meeting

    London, UK
    April 20-21, 2026

    3rd International Conference on Ophthalmology

    Barcelona, Spain
    May 07-08, 2026

    7th International Conference on Optometry

    Paris, France
    May 25-26, 2026

    10th World Congress on Eye and Vision

    Madrid, Spain
    September 14-15, 2026

    40th European Ophthalmology Congress

    Rome, Italy
    September 14-15, 2026

    7th World Congress on Ophthalmology and Vision Science

    Rome, Italy

    Uveitis & Ocular Inflammation – Immune Insights Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in